Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
FDA Rejects Nuplazid Application for Treatment of Alzheimer’s Disease Psychosis The agency said more clinical trials would be required showing clearer results before it could approve Nuplazid to treat Alzheimer’s disease psychosis. August 8, 2022 Russell Maas Add Your Comments Following thousands of reported side effects from Nuplazid, a blockbuster antipsychotic drug that was fast tracked through the FDA approval process a few years ago, federal health regulators have rejected an application by Acadia Pharmaceuticals to expand use of the drug to treat symptoms of Alzheimer’s disease psychosis. Nuplazid (pimavanserin) was introduced in April 2016, as a medication to help reduce the frequency and severity of hallucinations experienced by Parkinson’s disease patients. The drug approved by the U.S. Food and Drug Administration (FDA) through a fast track “Breakthrough Therapy” process, but post-marketing follow up has identified thousands of Nuplazid problems, including at least 700 deaths that may be linked to use of the drug. While the adverse event reports are not proof Nuplazid caused those deaths and injuries, at least 500 of the fatalities reported to the FDA listed Nuplazid as the only suspect medication taken by the patient at the time. As a result, a growing number of Nuplazid lawsuits have been filed by individuals who have suffered serious injuries, deaths, or ongoing hallucinations, which claim the drug maker failed to adequately warn about the risks associated with their medication. Learn More About Nuplazid Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Nuplazid Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Last week, the FDA issued a Complete Response Letter (CRL) to Acadia Pharmaceutical’s supplemental New Drug Application (sNDA), rejecting the manufacturer’s application to approve the drug to treat hallucinations and delusions associated with Alzheimer’s disease psychosis. According to the FDA’s rejection letter, the agency indicates the positive results in Acadia’s Study 045 were largely driven by a subgroup which included patients being treated for Parkinson’s disease psychosis, which is a condition that has already been approved for use. The FDA further stated that while the drug’s efficacy to treat patients was noted in Acadia’s Study 019, the study lacks interpretability and contains limitations, which create the potential for unknown adverse events in patients. The rejection mirrors a similar decision by the FDA not to approve Nuplazid for use in treating dementia-related psychosis in April 2021. The FDA instructed Acadia’s Nuplazid medication in its present form could not be approved for the treatment of Alzheimer’s disease psychosis, and recommended the company to run additional clinical trials. The rejection came as a surprise to Acadia Pharmaceuticals, who reportedly stated the results of the FDA’s CRL were disappointing, and expressed their gratitude to all of the patients, families and investigator who helped design and run the clinical trials. Reports of Nuplazid Side Effects The Institute for Safe Medication Practices (ISMP) issued a warning about Nuplazid safety signals in its November 2017 QuarterWatch report, indicating that the FDA had received 2,236 adverse event reports over the course of its first year on the market, including 244 deaths and signs that the drug may actually worsen hallucinations in some cases. ISMP later released its QuarterWatch Report in 2019, finding hundreds of reports involving problems with Nuplazid, which suggested federal regulators may have made a mistake when they determined that the antipsychotic drug Nuplazid was safe. Tags: Acadia Pharmaceuticals, Alzheimer's Disease, Atypical Antipsychotic, Nuplazid, Psychosis Image Credit: | More Nuplazid Lawsuit Stories ISMP Report Questions Nuplazid Safety, FDA Approval And Lack Of Warnings March 29, 2019 Nuplazid Safety Risks May Lead FDA To Re-Review New Medication, Gottlieb Tells Senate April 26, 2018 Nuplazid Problems Linked To Hundreds Of Patient Deaths: Report April 11, 2018 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025) Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025) Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)
Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)
Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025)
Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)